GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invites Biocore Co Ltd (XKRX:216400) » Definitions » Net Income From Continuing Operations

Invites Biocore Co (XKRX:216400) Net Income From Continuing Operations : ₩-10,754 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Invites Biocore Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Invites Biocore Co's net income from continuing operations for the six months ended in Dec. 2024 was ₩-10,754 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-10,754 Mil.

Invites Biocore Co Net Income From Continuing Operations Historical Data

The historical data trend for Invites Biocore Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invites Biocore Co Net Income From Continuing Operations Chart

Invites Biocore Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,980.59 708.55 -2,546.09 -8,177.59 -10,753.73

Invites Biocore Co Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,980.59 708.55 -2,546.09 -8,177.59 -10,753.73

Invites Biocore Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-10,754 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invites Biocore Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invites Biocore Co Ltd (XKRX:216400) » Definitions » Net Income From Continuing Operations
Comparable Companies
XKRX:373110 XKRX:354200 XKRX:284620 XKRX:432980 XKRX:291650 XKRX:225220 XKRX:263050 XKRX:288330 XKRX:032790 XKRX:036480 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
60-21, Gasan-dong, IT Mi-Rae Tower, 9th Floor, Geumcheon-gu, Seoul, KOR
Website
http://www.bio-core.com
Invites Biocore Co Ltd, formerly Biocore Co Ltd is a biotechnology company. It experiments on biological organism for pharmaceutical companies, CRO, health care institutions and to pharmaceutical related research centers.

Invites Biocore Co Headlines

No Headlines